The expression of HER2 in TCs was also associated with shorter OS and DFS periods according to multivariate Cox regression analysis for HER2 expression, IDO expression, gender, age, pathologic tumor stage, and radiation therapy after surgery (p = 0.031 and p = 0.019, respectively) (Table 4). The gene discussed is ERBB2; the disease is neoplasm.